Abstract
Vitronectin, an integrinbinding a-l-glycoprotein with potent cell-adhesion and proliferation-mediating properties, has been shown to be incorporated in surgically removed membranes from patients with proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy (PDR) and macular pucker. Therefore we developed an ELISA technique to quantify levels of vitronectin in human vitreous and plasma samples in order to be able to evaluate the significance of vitronectin in these different vitreoretinal diseases. Our results indicate a significant increase of vitronectin in all proliferative disorders except idiopathic macular pucker. Adjustment of all probes to equal total protein content yielded a significant increase only in PDR (type 11 diabetes). Plasma samples demonstrated a significant increase of vitronectin in patients with type Il diabetes suffering from PDR. Therefore, break-down of the blood-retina barrier appears to be the most likely explanation for the increased levels of vitronectin in the vitreous. Our results indicate that vitronectin may not only be involved in the regulation of epiretinal membrane formation at significantly higher levels in patients with type II diabetes, but the increase of vitronectin in diabetic plasma may also help to explain the pathological alteration of the coagulation cascade in diabetics.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barnes DW, Silnutzer J (1983) Isolation of human serum spreading factor. J Biol Chem 258:12548–12552
Barnes DW, Silnutzer J (1983) Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci USA 80:1362–1366
Borsey DQ, Prowse DV, Gray RS, Dawes J, James K, Elton RA, Clarke BF (1984) Platelet and coagulation factors in proliferative diabetic retinopathy. J Clin Pathol 37:659–664
Buck CA, Horwitz AF (1987) Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol 3:179–205
Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG (1985) Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol 103:1403–1405
Christe M, Fritsche J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F (1984) Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemost 52:138–143
Conlan MG, Tomasini BR, Schultz RL, Mosher DF (1988) Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Blood 72:185–190
Dejana E, Colella S, Conforti G, Abbadini M, Gaboli M, Marchisio PC (1988) Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells. J Cell Biol 107:1215–1223
Esser P, Weller M, Heimann K, Wiedemann P (1990) Cell surface receptors for vitronectin and fibronectin in proliferative retinal disorders. Fortschr Ophthalmol 87:344–347
Esser P, Heimann K, Wiedemann P (1993) Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol 77:731–733
Gomez-Lechon MJ, Castell JV (1985) Enzyme linked immunosorbent assay to quantify fibronectin. Anal Biochem 145:1–8
Görg A, Postel W, Westermaier R, Gianazza E, Righetti PG (1980) Gel gradient electrophoresis, isoelectric focusing and two dimensional techniques in horizontal, ultrathin polyacrylamide layers. J Biochem Biophys Methods 3:273–284
Hetland G, Pettersen HB, Mollnes TE, Johnson E (1989) S-Protein is synthesized by human monocytes and macrophages in vitro. Scand J Immunol 29:15–21
Hiscott PS, Grierson I, McLeod D (1985) Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol 69:810–823
Holmes R (1967) Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol 32:297–308
Jones RL, Peterson CM (1979) Reduced fibrinogen survival in diabetes mellitus. J Clin Invest 63:485–493
Juliano RL (1987) Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochem Biophys Acta 907:261–278
Kanz L, Löhr GW, Preissner KT (1988) Identification of human megakaryocyte vitronectin/s-protein. Blood 72 [Suppl 1]:327a
Kunicki TJ (1989) Platelet membrane glycoproteins and their function: an overview. Cell 58:30–34
Landgraf-Leurs MMC, Ladik T, Smolka B, Bock T, Schramm W, Spannagl M, Landgraf R (1987) Increased thromboplastic potential in diabetes: a multifactorial phenomenon. Klin Wochenschr 65:600–606
Lowry OH, Rosebrough BJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1–23
Mimuro J (1991) Type 1 plasminogen activator inhibitor: its role in biological reactions. Rinsho Ketsueki 32:487–489
Musso R, Longo A, Cacciola RR, Lombardo A, Giustolisi R, Cacciola E (1989) Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothelium. Thromb Haemost 61:150–151
Parker CJ, Stone OL, White VF, Bernshaw NJ (1989) Vitronectin(S-protein) is associated with platelets. Br J Haematol 71:245–252
Podack ER, Preissner KT, Müller-Eberhard HJ (1984) Inhibition of C9 polymerisation within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand 92 [Suppl]:889–896
Preissner KT, Denne J (1991) Structure of vitronectin and its biological role in haemostasis. Thromb Haemost 66:123–132
Preissner KT, Denne J (1991) Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275–310
Preissner KT, Müller-Berghaus G (1986) S-protein modulates the heparin catalyzed inhibition of thrombin by anti-thrombin III. Eur J Biochem 156:645–650
Preissner KT, Holzhüter S, Justus C, Müller-Berghaus G (1989) Identification and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 74:1989–1996
Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238:491–497
Seiffert D, Mimuro J, Schleef RR, Loskutoff DJ (1990) Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Differ Dev 32:287–292
Setiadi H, Wautier MP, Guillausseau PJ, Lubetzki J, Caen J, Wautier JL (1989) Increase of endothelial cell growth by sera from diabetic patients with proliferative retinopathy. Lancet 334:1050
Shaffer MC, Foley TP, Barnes DW (1984) Quantitation of spreading factor in human biologic fluids. J Lab Clin Med 103:783–791
Towbin H, Gordon J (1984) Immunoblotting and dot immunobinding-current status and outlook. J Immunol Methods 72:313–340
Weller M, Heimann K, Wiedemann P (1988) Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal antihuman macrophage antibody. Graefe's Arch Clin Exp Ophthalmol 226:252–254
Weller M, Wiedemann P, Heimann K, Zilles K (1988) The significance of fibronectin in vitreoretinal pathology: a critical evaluation. Graefe's Arch Clin Exp Ophthalmol 226:294–298
Weller M, Wiedemann P, Heimann K, Zilles K (1988) Fibronectin quantification in plasma and vitreous by a non-competitive ELISA technique. Doc Ophthalmol 69:341–351
Weller M, Heimann K, Wiedemann P (1989) Immunochemical analysis of periretinal membranes. Review and outlook. Dev Ophthalmol 16:56–74
Weller M, Wiedemann P, Bresgen M, Heimann K (1991) Vitronectin and proliferative vitreoretinal disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitre-oretinopathy. Int Ophthalmol 15:93–101
Weller M, Wiedemann P, Bresgen M, Heimann K (1991) Vitronectin and proliferative vitreoretinal disorders. II. Expression of cell-surface receptors for fibronectin and vitronectin in periretinal membranes. Int Ophthalmol 15:93–101
Wiedemann P, Weller M (1988) The pathophysiology of proliferative vitre-oretinopathy. Acta Ophthalmol [Suppl 189] 66:7–15
Wilson-Holt N, Khaw P, Savage F, Grierson I (1992) The chemoattractant activity of the vitreous to human scleral flbroblasts following retinal detachment and proliferative vitreoretinopathy. Br J Ophthalmol 76:159–162
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Esser, P., Bresgen, M., Weller, M. et al. The significance of vitronectin in proliferative diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol 232, 477–481 (1994). https://doi.org/10.1007/BF00195357
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00195357